eyeforpharma is now Reuters Events - LEARN MORE
Cross my heart and hope to die should not be the promise brokered between healthy volunteers entering a clinical trial.
by Jill Donahue
How to make those resolutions stick.
by Marc Yates
The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.
The PR & MA environment is evolving at a fast pace and securing access at the right price remains challenging.
Have we gone too far with patient centricity?